Literature DB >> 9510108

True community-acquired methicillin-resistant Staphylococcus aureus bacteremia.

J Akram, A E Glatt.   

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) recently has been reported as an outpatient pathogen. We assessed this and found our institution's frequency quite low. Only 16 patients (4%) had true community-acquired MRSA bacteremia. Ten had no recorded previous hospitalization; twelve (75%) had significant underlying medical problems. Substance abuse and prior outpatient antibiotic use were not identified as major risks for community-acquired MRSA bacteremia.

Entities:  

Mesh:

Year:  1998        PMID: 9510108     DOI: 10.1086/647775

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  5 in total

1.  Prevalence of oxacillin resistance in Staphylococcus aureus among inpatients and outpatients in the United States during 2000.

Authors:  Mark E Jones; David C Mayfield; Clyde Thornsberry; James A Karlowsky; Daniel F Sahm; Dan Peterson
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

2.  Is methicillin-resistant Staphylococcus aureus an emerging community pathogen? A review of the literature.

Authors:  M A Gardam
Journal:  Can J Infect Dis       Date:  2000-07

3.  Community-acquired methicillin-resistant Staphylococcus aureus, Finland.

Authors:  Saara Salmenlinna; Outi Lyytikäinen; Jaana Vuopio-Varkila
Journal:  Emerg Infect Dis       Date:  2002-06       Impact factor: 6.883

Review 4.  Methicillin-Resistant Staphylococcus aureus in the Oral Cavity: Implications for Antibiotic Prophylaxis and Surveillance.

Authors:  Eric S Donkor; Fleischer Cn Kotey
Journal:  Infect Dis (Auckl)       Date:  2020-12-14

5.  Community-acquired methicillin-resistant Staphylococcus aureus in institutionalized adults with developmental disabilities.

Authors:  Abraham Borer; Jacob Gilad; Pablo Yagupsky; Nechama Peled; Nurith Porat; Ronit Trefler; Hannah Shprecher-Levy; Klaris Riesenberg; Miriam Shipman; Francisc Schlaeffer
Journal:  Emerg Infect Dis       Date:  2002-09       Impact factor: 6.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.